NNovartis Read More Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed2026-05-19 Novartis Pharma AG Ad hoc announcement pursuant to Art. 53 LR First quarter Net sales declined -5% (cc1,…
NNovartis Read More Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed2026-04-28 Novartis Pharma AG Ad hoc announcement pursuant to Art. 53 LR First quarter Net sales declined -5% (cc1,…